Nobili V - Search Results

1

The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?

Nobili V, Alisi A, Mosca A, Crudele A, Zaffina S, Denaro M, Smeriglio A, Trombetta D. Nobili V, et al. Antioxid Redox Signal. 2019 Jul 10;31(2):127-133. doi: 10.1089/ars.2018.7704. Epub 2019 Feb 11. Antioxid Redox Signal. 2019. PMID: 30588836 Clinical Trial.

2

Nonalcoholic fatty liver disease in children.

Alisi A, Locatelli M, Nobili V. Alisi A, et al. Among authors: nobili v. Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):397-402. doi: 10.1097/MCO.0b013e32833aae84. Curr Opin Clin Nutr Metab Care. 2010. PMID: 20531177 Review.

3

Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments.

Alisi A, Nobili V. Alisi A, et al. Among authors: nobili v. Nutrition. 2012 Jul;28(7-8):722-6. doi: 10.1016/j.nut.2011.11.017. Epub 2012 Mar 28. Nutrition. 2012. PMID: 22464551 Review.

4

Paediatric nonalcoholic fatty liver disease.

Alisi A, Carpino G, Nobili V. Alisi A, et al. Among authors: nobili v. Curr Opin Gastroenterol. 2013 May;29(3):279-84. doi: 10.1097/MOG.0b013e32835ff95e. Curr Opin Gastroenterol. 2013. PMID: 23493072 Review.

5

Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.

Della Corte C, Liccardo D, Ferrari F, Alisi A, Nobili V. Della Corte C, et al. Among authors: nobili v. Expert Opin Pharmacother. 2014 Dec;15(17):2501-11. doi: 10.1517/14656566.2014.960389. Epub 2014 Sep 15. Expert Opin Pharmacother. 2014. PMID: 25219959 Review.

6

Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.

Mann JP, De Vito R, Mosca A, Alisi A, Armstrong MJ, Raponi M, Baumann U, Nobili V. Mann JP, et al. Among authors: nobili v. Hepatology. 2016 Mar;63(3):745-53. doi: 10.1002/hep.28374. Epub 2016 Jan 14. Hepatology. 2016. PMID: 26638195

7

Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.

Zöhrer E, Alisi A, Jahnel J, Mosca A, Della Corte C, Crudele A, Fauler G, Nobili V. Zöhrer E, et al. Among authors: nobili v. Appl Physiol Nutr Metab. 2017 Sep;42(9):948-954. doi: 10.1139/apnm-2016-0689. Epub 2017 May 16. Appl Physiol Nutr Metab. 2017. PMID: 28511023 Clinical Trial.

8

Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.

Giorgio V, Mosca A, Alterio A, Alisi A, Grieco A, Nobili V, Miele L. Giorgio V, et al. Among authors: nobili v. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):150-155. doi: 10.1097/MPG.0000000000001614. J Pediatr Gastroenterol Nutr. 2017. PMID: 28737569

9

Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease?

Loffredo L, Zicari AM, Perri L, Carnevale R, Nocella C, Angelico F, Del Ben M, Mosca A, Zaffina S, Panera N, Alisi A, Duse M, Violi F, Nobili V. Loffredo L, et al. Among authors: nobili v. Antioxid Redox Signal. 2019 Apr 1;30(10):1325-1330. doi: 10.1089/ars.2018.7596. Epub 2018 Aug 17. Antioxid Redox Signal. 2019. PMID: 30019598

10

In a pilot study, reduced fatty acid desaturase 1 function was associated with nonalcoholic fatty liver disease and response to treatment in children.

Nobili V, Alisi A, Liu Z, Liang T, Crudele A, Raponi M, Lin J, Chalasani NP, Liu W. Nobili V, et al. Pediatr Res. 2018 Nov;84(5):696-703. doi: 10.1038/s41390-018-0132-7. Epub 2018 Aug 4. Pediatr Res. 2018. PMID: 30120404 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page